MX2021013191A - Method and process for in vitro decellularization of cardiovascular tissue. - Google Patents
Method and process for in vitro decellularization of cardiovascular tissue.Info
- Publication number
- MX2021013191A MX2021013191A MX2021013191A MX2021013191A MX2021013191A MX 2021013191 A MX2021013191 A MX 2021013191A MX 2021013191 A MX2021013191 A MX 2021013191A MX 2021013191 A MX2021013191 A MX 2021013191A MX 2021013191 A MX2021013191 A MX 2021013191A
- Authority
- MX
- Mexico
- Prior art keywords
- tissue
- cardiovascular tissue
- recirculation system
- decellularization
- vitro
- Prior art date
Links
- 230000002526 effect on cardiovascular system Effects 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 238000000338 in vitro Methods 0.000 title abstract 2
- 210000001519 tissue Anatomy 0.000 abstract 6
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000000170 cell membrane Anatomy 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 230000000593 degrading effect Effects 0.000 abstract 1
- 210000002744 extracellular matrix Anatomy 0.000 abstract 1
- 210000003709 heart valve Anatomy 0.000 abstract 1
- 239000000815 hypotonic solution Substances 0.000 abstract 1
- 239000000644 isotonic solution Substances 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 229940021222 peritoneal dialysis isotonic solution Drugs 0.000 abstract 1
- 210000001147 pulmonary artery Anatomy 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000003462 vein Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Abstract
The present invention refers to a method and process for in vitro decellularization of cardiovascular tissue, such as heart valves, pulmonary arteries, large vessels, veins, and peripheral arterial networks. It consists of a) subjecting the cardiovascular tissue to a recirculation system of Decellularizing hypotonic solutions in a stepwise concentration gradient to lyse cells from the plasma membrane but keeping the extracellular matrix intact, b) subjecting the cardiovascular tissue to a recirculation system of nucleic acid degrading enzymes to eliminate cellular debris in the tissue, and c) submitting the cardiovascular tissue to a recirculation system of isotonic solutions to remove toxic residues and preserve the structural integrity of the tissue.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2021013191A MX2021013191A (en) | 2021-10-27 | 2021-10-27 | Method and process for in vitro decellularization of cardiovascular tissue. |
PCT/MX2021/050071 WO2023075586A1 (en) | 2021-10-27 | 2021-10-29 | Method and process for in vitro decellularisation of cardiovascular tissue |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2021013191A MX2021013191A (en) | 2021-10-27 | 2021-10-27 | Method and process for in vitro decellularization of cardiovascular tissue. |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021013191A true MX2021013191A (en) | 2023-04-28 |
Family
ID=86160131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021013191A MX2021013191A (en) | 2021-10-27 | 2021-10-27 | Method and process for in vitro decellularization of cardiovascular tissue. |
Country Status (2)
Country | Link |
---|---|
MX (1) | MX2021013191A (en) |
WO (1) | WO2023075586A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6734018B2 (en) * | 1999-06-07 | 2004-05-11 | Lifenet | Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced |
US20110165676A1 (en) * | 2009-11-06 | 2011-07-07 | The Children's Mercy Hospital | Method for decellularization |
US11590261B2 (en) * | 2014-04-02 | 2023-02-28 | Biotronik Ag | Method for the preparation of biological tissue for dry use in an implant |
GB2543540B (en) * | 2015-10-21 | 2020-10-14 | Videregen Ltd | Decellularising tissue |
-
2021
- 2021-10-27 MX MX2021013191A patent/MX2021013191A/en unknown
- 2021-10-29 WO PCT/MX2021/050071 patent/WO2023075586A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2023075586A1 (en) | 2023-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zia et al. | Hearts beating through decellularized scaffolds: whole-organ engineering for cardiac regeneration and transplantation | |
Gilbert et al. | Decellularization of tissues and organs | |
CN108130308B (en) | Cryopreservation resuscitation method for umbilical cord tissue | |
Crapo et al. | An overview of tissue and whole organ decellularization processes | |
Sawada et al. | Cell removal with supercritical carbon dioxide for acellular artificial tissue | |
Rabbani et al. | Contribution of physical methods in decellularization of animal tissues | |
CN103990179B (en) | A kind of method for preparing xenogenesis acellular matrix and products thereof | |
EP2538988B1 (en) | Methods for tissue decellularization | |
WO2019155031A3 (en) | Bioprocessing methods for cell therapy | |
JP2013502275A5 (en) | ||
WO2006095342A3 (en) | Natural tissue-derived decellularized matrix and methods of generating and using same | |
WO2008054825A3 (en) | Mixed cell populations for tissue repair and separation technique for cell processing | |
US9827350B2 (en) | Solubilization of antigen components for removal from tissues | |
WO2018207493A1 (en) | Method for producing decellularized tissue, decellularized tissue, and apparatus for producing decellularized tissue | |
US11060057B2 (en) | Presaturation of supercritical CO2 with water for decellularization of matrices | |
RU2012130928A (en) | METHOD FOR CULTIVATION OF ADHESION CELLS | |
MX2023002103A (en) | Methods and apparatuses for purification of gel droplets supporting biological tissue. | |
Roehm et al. | In vitro characterization of acelluar porcine adipose tissue matrix for use as a tissue regenerative scaffold | |
MX2021013191A (en) | Method and process for in vitro decellularization of cardiovascular tissue. | |
CA2507498A1 (en) | Method of treating biological tissue for transplantation by applying ultrahigh hydrostatic pressure | |
Morimoto et al. | The superiority of the autografts inactivated by high hydrostatic pressure to decellularized allografts in a porcine model | |
Sokol et al. | Comparison of bovine pericardium decellularization protocols for production of biomaterial for cardiac surgery | |
WO2007087570A3 (en) | Polymerized hemoglobin media and its use in isolation and transplantation of islet cells | |
Ellis et al. | Adipose stem cell secretome markedly improves rodent heart and human induced pluripotent stem cell-derived cardiomyocyte recovery from cardioplegic transport solution exposure | |
RU2012104553A (en) | CELLS PRODUCED FROM CARDIAL FABRIC |